| Issue Date | Title | Author(s) |
| 2020-12 | A phospholipid-based formulation for the treatment of airway inflammation in chronic respiratory diseases | Komalla, V; Allam, VSRR; Kwok, PCL; Sheikholeslami, B; Owen, L; Jaffe, A; Waters, SA; Mohammad, S; Oliver, BG; Chen, H; Haghi, M |
| 2020-08-20 | Animal and translational models of SARS-CoV-2 infection and COVID-19. | Johansen, MD; Irving, A; Montagutelli, X; Tate, MD; Rudloff, I; Nold, MF; Hansbro, NG; Kim, RY; Donovan, C; Liu, G; Faiz, A; Short, KR; Lyons, JG; McCaughan, GW; Gorrell, MD; Cole, A; Moreno, C; Couteur, D; Hesselson, D; Triccas, J; Neely, GG; Gamble, JR; Simpson, SJ; Saunders, BM; Oliver, BG; Britton, WJ; Wark, PA; Nold-Petry, CA; Hansbro, PM |
| 2020-05 | Critical role for iron accumulation in the pathogenesis of fibrotic lung disease. | Ali, MK; Kim, RY; Brown, AC; Donovan, C; Vanka, KS; Mayall, JR; Liu, G; Pillar, AL; Jones-Freeman, B; Xenaki, D; Borghuis, T; Karim, R; Pinkerton, JW; Aryal, R; Heidari, M; Martin, KL; Burgess, JK; Oliver, BG; Trinder, D; Johnstone, DM; Milward, EA; Hansbro, PM; Horvat, JC |
| 2021-01-27 | BET proteins are associated with the induction of small airway fibrosis in COPD. | Zakarya, R; Chan, YL; Rutting, S; Reddy, K; Bozier, J; Woldhuis, RR; Xenaki, D; Van Ly, D; Chen, H; Brandsma, C-A; Adcock, IM; Oliver, BG |
| 2014-01 | Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis. | Jaffar, J; Unger, S; Corte, TJ; Keller, M; Wolters, PJ; Richeldi, L; Cerri, S; Prêle, CM; Hansbro, PM; Argraves, WS; Oliver, RA; Oliver, BG; Black, JL; Burgess, JK |
